As calls rise for booster dose to the vulnerable population after the detection of possibly more transmissible Omicron variant, Serum Institute of India will be slashing their Covishield production capacity by 50 per cent in view of no new orders from the Center.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3m62kXl
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Effectiveness of vaccines against Omicron uncertain as calls for booster dose rise
https://ift.tt/eA8V8J
No comments:
Post a Comment